Basic & Clinical Medicine ›› 2023, Vol. 43 ›› Issue (7): 1110-1116.doi: 10.16352/j.issn.1001-6325.2023.07.1110

• Original Articles • Previous Articles     Next Articles

Mesenchymal stem cell-engineered DNA nanostructures and the application in targeted delivery to the lungs of mice

LI Zhuoting1, SHANG Yingxu2, WANG Haiyan1, JIANG Qiao2, DING Baoquan2, LI Jing1,*, ZHAO Chunhua1,*   

  1. 1. Center for Excellence in Tissue Engineering, Institute of Basic Medical Sciences CAMS, School of Basic Medicine PUMC, Beijing 100005;
    2. CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China
  • Received:2023-03-21 Revised:2023-05-23 Published:2023-07-05

Abstract: Objective Modifying 3D tubular DNA origami nanostructures (DONs) onto the mesenchymal stem cells (MSCs) membrane surface to obtain DONs@MSCs. Utilizing the characteristics of MSCs homing lung tissue to achieve targeted delivery of DONs to the lungs of mice. Methods The computer-aided tools for DNA sequence were used to design and obtain obtain pre-designed DONs. The morphology of assembled DONs was characterized by atomic force microscopy(AFM), and the upload of functional groups was verified by agarose gel electrophoresis (AGE). Fluorescent labeled single-strand DNA(ssDNA) was modified on the surface of MSCs using biological orthometabolic sugar engineering. According to the principle of complementary base pairing, DONs were modified on the MSCs surface. Using confocal microscopy and flow cytometry to detect the ssDNA and DONs, and using in vivo imaging to observe the distribution of DONs in lung tissue. Results DONs had been successfully assembled. MSCs membrane surface was successfully modified with ssDNA, and DONs were successfully hybridized to obtain DONs@MSCs. Compared to DONs, the enrichment of DONs@MSCs in the lungs of mice was significantly enhanced. Conclusions DONs@MSCs can be used for DONs targeted delivery to lung tissue of mice. This method provides a new strategy for drug delivery of DONs in lung tissues.

Key words: mesenchymal stem cells, DNA origami nanostructures, targeted delivery

CLC Number: